Navigation Links
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Date:5/15/2008

All statements that address expectations or projections about the future, including without limitation, statements about the Company's strategy for growth, product development, product launches, regulatory approvals, market position, market share increases, acquisitions, revenues, expenditures and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, KV provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transdel Pharmaceuticals Closes $4 Million Financing
2. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
3. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Illinois Pharmaceutical Manufacturer Sued for Injuries to Kentucky Resident
5. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
6. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
7. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
9. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
10. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
11. Medimetriks Pharmaceuticals, Inc. Begins Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 Genedata, a leading ... drug discovery, and life science research, today announced ... as its bioinformatics platform for strain genome ... will provide AB Enzymes, one of the world’s ... solution of Genedata Selector accompanied by bioinformatics consulting ...
(Date:5/22/2013)... New York, NY (PRWEB) May 22, 2013 ... My Cleaning Products said that there is a way to ... victims, it included on its latest post the details of ... spending too much money. , Mold could be prevented, My ... preventive measures, the company stated that a mold remediation must ...
(Date:5/22/2013)... West Chester, PA (PRWEB) May 22, 2013 ... the company as Fermentation Manager. Mr. McErlean has ... a variety of leadership positions throughout his career. ... stated, “We are very pleased to have Mike join ... our newly installed large scale fermentation and ...
(Date:5/22/2013)...  Moderna Therapeutics, the pioneering company developing messenger RNA ... in vivo production of therapeutic proteins, announced ... join Moderna in early July as its first Chief ... leader in the design and implementation of information systems ... translation, clinical operations and commercial preparedness. John has also ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3
... A delegation led by Governor Doyle and organized by ... the biotechnology industrys leading conference with goals to establish ... and university community and to let others know that ... of the group, the delegation met its objectives in ...
... companies who dont panic, that will continue to grow and ... working on a project for the Council for Continuous Improvement ... was arranging and conducting seminars for executives in the auto ... make or break situation with many quality control issues. During ...
... GE Medical Systems, a unit of General Electric Company, ... U.S. Food and Drug Administration to begin marketing its ... The Signa EXCITE 3.0T combines the increased speed and ... breadth of imaging capabilities found on premium 1.5 Tesla ...
Cached Biology Technology:On site at BIO 2003 2On site at BIO 2003 3On site at BIO 2003 4On site at BIO 2003 5A Race without a Finish Line! 2GE Medical Systems Receives FDA Clearance for New MRI System 2
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
... 16, 2010 (Toronto) New research from the Centre ... Sick Children (SickKids), both in Toronto, Canada provides further clues ... more males than females. The scientists discovered that males who ... carry are at high risk of developing ASD. The research ...
... , , , , , ... , AUDIO: When men outnumber women, ... Click here for more information. , , , ... , , , , , , ...
... led by Boston University biomedical engineering researchers has won ... of Health to refine its nanoscale, low-cost, ultra-fast DNA ... for less than $1,000. Developed in the ... grant and led by Boston University Biomedical Engineering Professor ...
Cached Biology News:Link to autism in boys found in missing DNA 2Women: Hope to marry young? Head to Alaska, steer clear of Alabama 2Women: Hope to marry young? Head to Alaska, steer clear of Alabama 3Women: Hope to marry young? Head to Alaska, steer clear of Alabama 4BU team wins $4.1M genome grant 2
BKBeta2 potassium channel Antigen: Fusion protein amino acids 1-41 (N-terminus) and 218-235 (C-terminus) of mouse BKBeta2 Accession Number: Q9CZM9...
POU domain, class 2, transcription factor 2,...
... HEK 293T cell line contains the b-lactamase ... response element (CRE). To obtain the cell ... HEK 293T cells by lentivirus. Subsequent flow ... to forskolin stimulation (Figure 1). The CellSensor ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
Biology Products: